Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Public health impact and cost effectiveness of routine and catch-up vaccination of girls and women with a nine-valent HPV vaccine in Japan: a model-based study

Fig. 1

Population-level health impact of routine and alternative strategies of vaccinating girls and women aged 12 through 26 years on 9-valent HPV-related (a) cervical cancer and (b) cervical cancer death. GOV-4vHPV included routine vaccination of 12–16-year old girls with 4vHPV from 2021 onwards; GOV-9vHPV included routine vaccination of 12–16-year old girls with 9vHPV; GOV + Catch-Up-9vHPV consisted of routine vaccination of 12–16-year old girls from 2021 onwards and temporary catch-up vaccination of 17–26 years old girls and women with 9vHPV until 2025. All vaccination strategies were combined with cervical cancer screening

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us